‹ All Posts
CA ATIN AGRRAWAL

30th Oct · SEBI-Registered Analyst

NEULANDLAB

NEULANDLAB
Neuland Labs is an Indian contract development & manufacturing organisation (CDMO) specialising in Active Pharmaceutical Ingredients (APIs), advanced intermediates and peptide APIs. Headquartered in Hyderabad, India. Key business segments: Generic drug substances + custom manufacturing solutions + peptide APIs. 52-week range: ₹10,190.70 (low) to ₹18,100.00 (high). Market capitalization: ~ ₹20,500 – 21,000 crore. Key valuation ratios: P/E (TTM) 116.85× according to Groww. P/B 13.5× roughly.

#WatchOutFor#Budget2025#TechnicalViews#Post-ClosingCommentary#HiddenGems
NEULANDLAB_2025-10-30_23-22-24.png
456 likes·66 comments